OPERATING SEGMENTS

9 Months Ended

Mar. 31, 2012

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

16.  OPERATING SEGMENTS

The Company operates in two operating segments which are consistent with its internal organization. The major segments are medical diagnostic services and government contracting.  Where applicable, “Unallocated” represents items necessary to reconcile to the consolidated financial statements, which generally include corporate activity at the parent level and eliminations.

The Company evaluates performance of individual operating segments based on operating income (loss). On a consolidated basis, this amount represents total net loss as shown in the consolidated statement of operations. Reconciling items represent executive compensation costs that are not allocated to the operating segments.  Such costs have not been allocated from the parent to the subsidiaries.

	Three Months Ended March 31, 2012
	Medical Diagnostics			Government Contracting			Unallocated			Total
Revenues	$	50,537		$	104,300		$	-		$	154,837
Operating loss		(85,094	)		(244,068	)		(224,167	)		(553,329	)
Other income		-			6,720			-			6,720
Interest expense		2,995			7,448			-			10,443
Depreciation and amortization		1,106			43,750			-			44,856
Expenditure for long-lived assets, including intangibles		12,300			-			-			12,300

	Three Months Ended March 31, 2011
	Medical Diagnostics			Government Contracting			Unallocated		Total
Revenues	$	110,099		$	52,881		$	-	$	162,980
Operating loss		(400,415	)		(142,853	)		-		(543,268	)
Interest and other income		-			5,305			-		5,305
Interest expense		-			-			-		-
Depreciation and amortization		310			15,006			-		15,316
Expenditure for long-lived assets, including intangibles		4,200			-			-		4,200

	Nine Months Ended March 31, 2012
	Medical Diagnostics			Government Contracting			Unallocated			Total
Revenues	$	130,092		$	339,945		$	-		$	470,037
Operating loss		(490,099	)		(609,577	)		(417,334	)		(1,517,010	)
Other income		-			115,489			-			115,489
Interest expense		8,901			7,448			-			16,349
Depreciation and amortization		1,726			131,250			-			132,976
Expenditure for long-lived assets, including intangibles		34,100			-			-			34,100
Total Assets at March 31, 2012		106,968			191,215			5,000,000			5,298,183

	Nine Months Ended March 31, 2011
	Medical Diagnostics			Government Contracting			Unallocated		Total
Revenues	$	181,526		$	52,881		$	-	$	234,407
Operating loss		(917,393	)		(142,853	)		-		(1,060,246	)
Interest and other income		-			5,305			-		5,305
Interest expense		-			-			-		-
Depreciation and amortization		516			15,006			-		15,522
Expenditure for long-lived assets, including intangibles		10,391			-			-		10,391
Total Assets at March 31, 2011		305,616			1,568,969			5,036,000		6,910,585